Orphazyme has dismissed co-founder and chief scientific officer
Thomas Kirkegaard Jensen is no longer a part of biotech company Orphazyme, which he helped found in 2009. According to CEO Anders Vadsholt, it’s been necessary to make prioritizations, a sentiment that is met by understanding from the departing co-founder.
by CHRISTOPHER DUE KARLSSON, translated by daniel pedersen
Thomas Kirkegaard Jensen is no longer a part of the biotech company he helped found more than a decade ago, he informs MedWatch.
In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.
The US retail chain has stopped selling its own private label hearing aids – and until the next generation comes along, other hearing companies selling products via Costco are enjoying the empty shelf space.